Beauty Health Company (The) Overview
Beauty Health Company (The) (SKIN) has a P/E ratio of -3.1, below the Healthcare sector average of 24.78.
Get informed when a big investor buys or sells
+ Follow-3.10
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for SKIN is -3.1. That is below the Healthcare sector average of 24.78. Investors often review this figure alongside Beauty Health Company (The)'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, SKIN currently prints -3.1 for P/E ratio, while the sector average sits near 24.78. That is roughly 112.5% below the sector mean. Large gaps often invite a closer look at Beauty Health Company (The)'s growth, margins, and balance sheet.
A P/E ratio of -3.1 for Beauty Health Company (The) is not 'good' or 'bad' on its own. Compare it with the peer average (24.78) and with SKIN's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting SKIN's P/E ratio (-3.1), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Beauty Health Company (The)'s P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
